iBio, Inc. (IBIO) Receives Additional Canadian Patent Related to iBioModulator
Tweet Send to a Friend
iBio, Inc. (NYSE: IBIO) announced the issue of a new Canadian patent in the company's iBioModulator thermostable immunomodulator protein portfolio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
